Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status
- 194 Downloads
The aim of the present study was to map out what kind of psychotropic drugs are prescribed for elderly residents in assisted-living homes and how they relate to age, sex, form of living, psychiatric diagnosis, care needs and mental health status, and to identify factors of importance for their use; and to study the indication for treatment and the evaluation of the effects of treatment.
The study had a cross-sectional design and included one-third of all patients (n=175) living in old-age homes or in nursing homes in a municipality in southern Sweden. Data concerning medication was obtained from medical records and included all psychotropic drugs prescribed the day the study started and the previous month. Need of care was assessed using Katz index, and mental health status was assessed using the Organic Brain Syndrome scale.
Of the study population, 128 (73%) used one or more psychoactive drug. Prescribed drugs were neuroleptics (16%), anxiolytics (32%), hypnotics, (45%), and anti-depressants (33%). A greater prescription of neuroleptics than anti-depressants was seen for those showing signs of depression, and caution with prescription of benzodiazepines was seen for those showing signs of dementia. An indication and evaluation of treatment was lacking in half of the cases. Treatment with psychiatric drugs existed for approximately 50% of those without a determined psychiatric diagnosis.
We have found a frequent use of neuroleptics, anxiolytics and hypnotics in the elderly, but an underprescription of anti-depressants appears to exist. There is a lack of documentation of indications and evaluations of psychotropic medication.
KeywordsElderly Nursing home Old-age homes
The authors wish to thank all staff members and residents at the nursing homes and old-age homes for their collaboration. We are most grateful to Christin Tornvall for help with interviews and to Anders Håkansson, Ph.D., for revising the language. The study was supported by Capio Research Foundation.
- 1.SCB (2001) Sweden's official statistics, statistical announcements BE 12 SM 0101. Population of the whole country, the counties and the municipalities 31 December 2000 (in Swedish). Statistiska Centralbyrån, StockholmGoogle Scholar
- 3.Burns A (1997) Psychiatric symptoms and behavioural disturbances in the dementias. J Neural Transm 51:27–35Google Scholar
- 8.Schjott J, Opedal K, Rutledal JE (1999) A survey of hypnotic use in geriatric institutions in Sogn og Fjordane, Norway. Aging Clin Exp Res 11:50–55Google Scholar
- 13.Fastbom J (2001) Elderly and drugs. Liber, StockholmGoogle Scholar
- 27.Henderson AS, Korten AE, Jorm AF, et al (1994) Are nursing homes depressing? Lancet 344:1091Google Scholar
- 30.Katz S, Ford AB, Moskowits RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914–919Google Scholar
- 32.Jensen E, Dehlin O, Gustafson G (1993) A comparison between three psychogeriatric rating scales. Int J Geriatr Psychiatry 8:215–229Google Scholar
- 33.WHO Collaborating Centre for Drugs Statistics and Methodology (2000) Anatomical therapeutic chemical (ATC) classification index. World Health Organisation, OsloGoogle Scholar
- 34.The National Board of Health and Welfare (1997) International classification of diseases and related health problems, tenth revision (ICD-10). StockholmGoogle Scholar
- 35.SPSS (1993) Base system users guide. SPSS, Inc., ChicagoGoogle Scholar
- 36.The National Board of Health and Welfare (1998) Ädelparadoxen: sjukhemmen före och efter Ädelreformen (in Swedish). StockholmGoogle Scholar
- 40.Roberts MS, King M, Stokes JA, et al (1998) Medication prescribing and administration in nursing homes. Age Ageing 27:385–392Google Scholar
- 41.Newman SC, Hassan AI (1999) Antidepressant use in the elderly population in Canada: results from a national survey. J Gerontol A Biol Sci Med Sci 54:527–530Google Scholar
- 43.Lader M (1997) Hypnotics in the elderly. Int J Geriatr Psychopharmacol 1:10–14Google Scholar
- 44.Bachman DL (1992) Sleep disorders with aging: evaluation and treatment. Geriatrics 47:53–61Google Scholar
- 45.Kennedy MM, Mion LC (1996) Neuroleptic therapy: how much do nurses know? J Gerontol Nurs 22:7–13Google Scholar
- 47.Miller SW (1993) Cost savings and reduction of medication related problems as a result of consultant pharmacy. Clin Pharm 8:1265–1271Google Scholar